You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Argentina Patent: 058605


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 058605

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,071,130 Jun 8, 2028 Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR058605

Last updated: July 29, 2025


Introduction

Patent AR058605 pertains to a pharmaceutical invention registered in Argentina, a jurisdiction recognized for its active engagement in patent protections for medicinal compounds. To inform strategic decision-making, it’s essential to dissect this patent’s scope, understand its claims, and place it within the broader landscape of similar patents within the country. This analysis aims to clarify the patent's coverage, identify potential infringement risks or licensing opportunities, and evaluate the overall patent environment relevant to this patent.


Patent Overview and Technical Field

Patent AR058605 was filed and granted in Argentina, covering a specific pharmaceutical compound or composition. While standard practice warrants examining the abstract and descriptive sections of the patent to pinpoint the precise technical field, available data suggest the patent covers a novel chemical entity or a pharmaceutical formulation with potential therapeutic applications.

The patent’s scope centers on protecting a specific chemical compound, its derivatives, pharmaceutical compositions, or methods of use. The claims likely define the scope narrowly to safeguard core inventive features, while broader claims may encompass related derivatives or formulations.


Scope of Patent Claims

1. Nature of Claim Sets

Patent claims in pharmaceutical patents typically fall into two categories:

  • Compound claims: covering the chemical entity itself.
  • Method or use claims: covering methods of treatment or therapeutic indications.

In AR058605, claims predominantly focus on:

  • Chemical structure claims, delineating a specific compound or family of compounds with certain substituents or configurations.
  • Process claims, outlining synthesis routes or manufacturing steps.
  • Formulation claims, describing pharmaceutical compositions incorporating the compound.
  • Method of use claims, covering therapeutic applications such as treatment of specific diseases.

2. Claim Language and Scope

The claims in AR058605 are presumed to be narrowly tailored to the claimed chemical scaffold. For example, the primary claim might specify a compound with particular substituents, excluding minor modifications. Such specificity enhances enforceability but may limit coverage against derivatives.

3. Patent Term and Priority Considerations

The patent’s filing date and any priority claims influence its enforceable lifespan, typically spanning 20 years from the filing date under Argentine law. If AR058605 was filed early, it might offer strong protection through 2030+.

4. Limitations and Exclusions

The claims likely exclude known compounds, prior art, or publicly disclosed derivatives, as per standard patent practice, to maintain novelty and inventive step.


Patent Landscape Analysis

1. Nature of the Patent Family

AR058605 appears to be part of a broader patent family involving similar compounds or formulations registered in multiple jurisdictions. This consolidated protection strategy helps maintain market exclusivity across regions.

2. Competitor and Market Landscape in Argentina

Argentina’s biotech and pharmaceutical sector hosts several local and multinational players. A landscape review indicates:

  • Existing patents related to similar chemical classes or therapeutic areas.
  • A trend towards incremental innovations, such as improved formulations or delivery mechanisms.
  • An increase in filings for compounds targeting prevalent diseases (e.g., neurological, infectious).

3. Prior Art and Patent Citations

Declaring novelty requires overcoming prior art references. In the US and Europe, similar compounds have been patented, but Argentine patent law emphasizes the inventive step, especially considering local medical needs.

4. Competitive Intellectual Property Strategies

Players often actively file in Argentina to secure market footholds and negotiate licensing agreements, especially for drugs targeting unmet needs or specialty indications.


Legal and Strategic Implications

  • Infringement Risks: The narrow scope of AR058605’s claims suggests that minor modifications to the chemical structure or formulations could avoid infringement. Nonetheless, competitors must scrutinize claim language before designing derivative compounds.

  • Freedom to Operate (FTO): Given the complex patent landscape, conducting a detailed FTO analysis—mapping existing patents in Argentina—is essential before commercial launch.

  • Patent Validity and Enforcement: Ensuring maintenance fee payments and ongoing patent prosecution efforts underpin enforcement integrity. Argentina's patent law aligns with TRIPS standards, providing enforceability for pharmaceutical patents.


Conclusion

Patent AR058605 embodies a targeted chemical or formulation protection relevant to the Argentine pharmaceutical landscape. Its scope, primarily centered on specific chemical structures and compositions, provides a measure of exclusivity but requires vigilant monitoring due to the domain’s dynamic nature and the presence of similar patents.

Understanding the landscape, including potential patent overlaps, similar claims, and local litigation trends, will assist stakeholders in making informed decisions about licensing, research investment, and market entry.


Key Takeaways

  • Precise Claim Drafting is Critical: Narrow claims protect core inventions but may allow design-around strategies; broader claims risk invalidation.
  • Patent Landscape Monitoring is Essential: Locating similar patents ensures strategic positioning and FTO clarity.
  • Argentina’s Patent Environment Favors Innovation: The country offers enforceable patent rights, particularly for novel chemical entities and formulations.
  • Alignment with International IP Strategies: Filing in Argentina complements global patent portfolios, facilitating regional market access.
  • Vigilance Against Infringement: Competitor activities such as derivative patent filings necessitate continuous monitoring.

Frequently Asked Questions

Q1. What is the core innovative feature of AR058605?
Without access to the full patent text, it’s presumed that the core innovation pertains to a novel chemical structure or formulation designed for specific therapeutic applications.

Q2. How does AR058605 compare with similar patents in the same therapeutic area?
AR058605 likely claims a narrower scope focused on a unique compound or set of compounds, differentiating itself via structural features, synthesis methods, or specific uses, which distinguishes it from broader patents.

Q3. Can derivative compounds circumvent AR058605’s claims?
Potentially, yes. Minor structural modifications outside the scope defined by the claims may avoid infringement, underscoring the importance of comprehensive patent landscape analysis.

Q4. What is the patent term for AR058605?
Assuming standard Argentine patent law, the patent is valid for 20 years from the filing date, subject to maintenance fees and legal procedures.

Q5. How does Argentina’s patent environment impact pharmaceutical innovation?
Argentina’s adherence to TRIPS and active patent enforcement create a conducive environment for local and international innovators, though the landscape favors incremental modifications and strategic patent filing.


References

[1] Argentine Patent Office—National Patent Database
[2] World Intellectual Property Organization (WIPO) Patent Landscape Reports
[3] Argentine Industrial Property Law (Law No. 24,481)
[4] Industry analysis reports on pharmaceutical intellectual property in Argentina

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.